BAGSVAERD, DENMARK--(Marketwire - August 11, 2011) -
Novo Nordisk A/S has today entered into an agreement to purchase 5,100,000
B shares (nominal DKK 1) of a value of DKK 2.9 billion from Novo A/S as
part of the ongoing DKK 10.0 billion share repurchase programme for 2011.
The transaction price is set to DKK 570.994 per share and has been
calculated as the average market price from 4 August to 10 August in the
open trading window following the announcement of Novo Nordisk's financial
results for the first six months of 2011.
Company Announcement no 51 2011: http://hugin.info/2013/R/1537718/469449.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE
[HUG#1537718]
Further information:
Media:
Outside North America:
Anne Margrethe Hauge
Tel: (+45) 4442 3450
Email Contact
In North America:
Ken Inchausti
Tel: (+1) 609 514 8316
Email Contact
Investors:
Klaus Bulow Davidsen
Tel: (+45) 4442 3176
Email Contact
Jannick Lindegaard
Tel: (+45) 4442 4765
Email Contact
Frank Daniel Mersebach
Tel: (+45) 4442 0604
Email Contact
Lars Borup Jacobsen
Tel: (+45) 3075 3479
Email Contact